Characteristics | Overall (n = 48) | Incremental HD (n = 23) | Conventional HD (n = 25) |
---|---|---|---|
Age at enrollment (years), mean (SD) | 62.02 (14.74) | 59.61 (15.33) | 64.33 (13.76) |
Female, n (%) | 21 (43) | 10 (43) | 11 (42) |
Race, n (%) | |||
 White | 19 (40) | 11 (48) | 8 (33) |
 Black | 26 (55) | 11 (48) | 16 (63) |
 Hispanic | 2 (4) | 1 (4) | 1 (4) |
KDRD etiology, n (%) | |||
 Diabetes mellitus | 24 (49) | 9 (39) | 15 (58) |
 Glomerulonephritis/Vasculitis | 2 (4) | 2 (9) | 0 (0) |
 Other/Unknown | 23 (47) | 12 (52) | 11 (42) |
Vascular Accessa, n (%) | |||
 Arteriovenous fistula | 9 (19) | 5 (22) | 4 (17) |
 Arteriovenous graft | 1 (2) | 0 (0) | 1 (4) |
 Central venous catheter | 38 (79) | 18 (78) | 20 (79) |
Comorbidities, n (%) | |||
 Diabetes mellitus | 30 (63) | 12 (52) | 18 (72) |
 Coronary artery disease | 8 (17) | 4 (17) | 4 (16) |
 Congestive heart failure | 11 (23) | 4 (17) | 7 (28) |
 Peripheral arterial disease | 5 (10) | 2 (9) | 3 (12) |
 Cerebrovascular disease | 8 (17) | 3 (13) | 5 (20) |
 Malignancy | 9 (19) | 3 (13) | 6 (24) |
 HIV | 2 (4) | 2 (9) | 0 (0) |
 Anxiety | 2 (4) | 0 (0) | 2 (8) |
 Depression | 3 (6) | 2 (9) | 1 (4) |
 Drug abuse | 1 (2) | 0 (0) | 1 (4) |
 Alcohol abuse | 2 (4) | 2 (9) | 0 (0) |
Medications | |||
 Anxiolytics | 1 (2) | 0 (0) | 1 (4) |
 Antidepressants | 0 (0) | 0 (0) | 0 (0) |
HD prescriptionb, mean (SD) | |||
 Treatment time (minutes) | 201.06 (35.09) | 204.13 (38.75) | 198.13 (30.92) |
 Blood flow (mL/min) | 304.26 (60.87) | 295.65 (62.40) | 312.50 (58.18) |
 Dialysate flow (mL/min) | 540.43 (84.20) | 530.43 (74.80) | 550.00 (91.29) |